ANRO 241018 15.00C (ANRO241018C15000) Stock Options, News & Quotes

0.70
-0.15-17.65%

15min DelayClose Oct 16 16:00 ET

1.00High0.50Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Stock Senior

Sep 9 09:28

Columns ANRO analysis

$Alto Neuroscience (ANRO.US)$ Alto Neuroscience, Inc. is a biotechnology company focused on developing personalized mental health treatments and is committed to improving the diagnosis and treatment of mental illness through precision medicine. The company mainly provides customized treatment plans for different individuals through the combination of neuroscience, artificial intelligence and data analysis.
Core business and technology:
Personalized Medication: Alto Neuroscience’s goa...

Jaguar8

Apr 23 07:36

$Alto Neuroscience (ANRO.US)$
NEWS
Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
ALTO-101 demonstrated favorable pharmacokinetic and tolerability profile in Phase 1 study
Transdermal formulation provided significantly greater drug exposure with fewer adverse events
Proof-of-concept study for CIAS to start in the first half of 2024
Topline data expected in the second half of 2025
Achievement of target exposure with propri...

Moomoo AI

Feb 27 11:21

Investment firms see Alto Neuroscience's biomarker approach as a potential boost for clinical trials and patient outcomes. They predict a high stock risk/reward into 2H 2024/1H 2025 readouts, with a possible 100%-200% rise on positive data.

Stifel, Baird, Jefferies Bullish on Alto Neuroscience, Cite Upcoming Data

DeeBe

Feb 2 11:49

$Alto Neuroscience (ANRO.US)$ let's get it